Alkermes
demonstrated dose dependent pharmacodynamic response similar to | Alkermes
Company
Deck Type
Sector
Industry
Deck date
June 2021
Slide
25 of 31
Related slides by other companies
Genelux
Investor Presentation
October 2023
demonstrated deep and durable tumor shrinkage | Genelux
Codiak
IPO
October 2020
dose dependent tumor growth inhibition and systemic tumor antigen specific immune response | Codiak
Genelux
Investor Presentation
July 2023
demonstrated deep and durable tumor shrinkage | Genelux
Genelux
Investor Presentation
December 2023
demonstrated deep and durable tumor shrinkage | Genelux
Other recent decks by Alkermes
See all presentations (22 decks)
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights